Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes
5/20/2013 1:52:58 PM
More...
|
Elcelyx Therapeutics Closes on $20 Million to Advance Appetite-Control Compounds
2/14/2013 6:58:03 AM
More...
|
Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
8/13/2012 9:56:29 AM
More...
|
Elcelyx Therapeutics Raises $4 Million
8/13/2012 7:45:21 AM
More...
|
Startup Elcelyx Therapeutics Raises $1.2 Million
3/19/2010 7:26:57 AM
More...
|